Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2013
12/05/2013WO2013153479A3 Indole and indazole compounds that activate ampk
12/05/2013US20130324718 Processes and reagents for making diaryliodonium salts
12/05/2013US20130324579 Novel pyrazole and imidazole derivatives useful as orexin antagonists
12/05/2013US20130324578 Administration regime for nitrocatechols
12/05/2013US20130324560 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
12/05/2013US20130324557 Compounds useful as modulators of trpm8
12/05/2013US20130324556 Protease Activated Receptor 2 (PAR2) Antagonists
12/05/2013US20130324538 Isoxazoline derivatives for controlling invertebrate pests
12/05/2013US20130324536 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
12/05/2013US20130324529 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
12/05/2013US20130324524 2,4-pyrimidinediamine compounds and their uses
12/05/2013US20130324522 Insect odorant receptor antagonists
12/05/2013US20130324518 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/05/2013US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
12/05/2013US20130324412 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
12/05/2013US20130323271 Nitric oxide donor neprilysin inhibitors
12/05/2013US20130323203 Inhibitors of flaviviridae viruses
12/04/2013EP2669283A1 Oxazolidinone derivative having 7-membered hetero ring
12/04/2013EP2669272A1 Indole derivative and pharmacologically acceptable salt of same
12/04/2013EP2669271A1 Indole derivative, and pharmacologically acceptable salt thereof
12/04/2013EP2669270A1 Ring-fused compound
12/04/2013EP2668183A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
12/04/2013EP2668182A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
12/04/2013EP2668179A1 New 5-alkynyl-pyridines
12/04/2013EP2668178A1 New 5-alkynyl-pyridines
12/04/2013EP2668177A1 Substituted pyridinyl-pyrimidines and their use as medicaments
12/04/2013EP2668165A1 Novel tetrahydroquinoline derivatives
12/04/2013EP2668162A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
12/04/2013EP2668157A1 Protease activated receptor 2 (par2) antagonists
12/04/2013EP2668155A2 New aryl-benzocycloalkyl amide derivatives
12/04/2013EP2667870A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013EP2499136B1 3-(3,4-dihydro-2h-benzo[1,4]oxazin-6-yl)-1h-pyrimidin-2,4-dione compounds as herbicides
12/04/2013CN103429589A Oxazine derivatives and their use in the treatment of neurological disorders
12/04/2013CN103429588A Crystalline oxazine derivative and its use as bace inhibitor
12/04/2013CN103429587A New azaspirodecanone compounds as HSL inhibitors
12/04/2013CN103429584A Quinoline derivatives as fungicides
12/04/2013CN103429583A Triazole derivatives as WNT signaling pathway inhibitors
12/04/2013CN103429582A MST1 kinase inhibitors and method of use thereof
12/04/2013CN103429578A Herbicide safener compositions
12/04/2013CN103420998A Synthesis method of novel oxadiazoles derivative
12/04/2013CN103420997A Pyrrole ketone-amine methyl-oxazolidinone compounds and preparation method and application of pyrrole ketone-amine methyl-oxazolidinone compounds
12/04/2013CN103420996A Benzopyrone-amine methyl-oxazolidinone compounds and preparation method and application of benzopyrone-amine methyl-oxazolidinone compounds
12/04/2013CN103420995A Oxazolidinone-alkyl amine group-furanone type compound and preparation method and application thereof
12/04/2013CN103420994A Dabigatran derivative used as prodrug, and preparation method and application thereof
12/04/2013CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine
12/04/2013CN101676284B Preparation method of nifuratel with high purity
12/04/2013CN101646664B Furanone compounds
12/04/2013CN101622243B Sulfonamide derivative
12/03/2013US8598342 Methods and compounds for antimicrobial intervention
12/03/2013US8598217 Imidazole derivatives and their use as modulators of cyclin dependent kinases
12/03/2013US8598206 Trypsin-like serine protease inhibitors, and their preparation and use
12/03/2013US8598179 Pyrazole-carboxamide derivatives as P2Y12 antagonists
12/03/2013US8598169 Biaryl compositions and methods for modulating a kinase cascade
12/03/2013US8598159 Therapeutic pyrazoloquinoline derivatives
12/03/2013US8598157 5-alkynyl-pyridines
12/03/2013US8597803 Light emitting devices and compositions
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
12/03/2013CA2516660C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/2013
11/28/2013WO2013175781A1 Pharmaceutical composition for inhalation
11/28/2013WO2013175431A1 Process for the preparation of rivaroxaban
11/28/2013WO2013174937A1 Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
11/28/2013WO2013174895A1 Heterocyclyl pyrimidine analogues as tyk2 inhibitors
11/28/2013WO2013174843A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxylic thioamides and use thereof as herbicides
11/28/2013WO2013174694A1 Crystalline form b of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione
11/28/2013WO2013174693A1 Crystalline form a of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione
11/28/2013WO2013121436A3 A process for preparation of rivaroxaban and intermediates thereof
11/28/2013US20130317230 Process For The Preparation Of Azilsartan Medoxomil
11/28/2013US20130317223 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
11/28/2013US20130317216 2,4-pyrimidinediamine compounds and their uses
11/28/2013US20130317215 Stable synthetic intermediate and method for manufacturing same
11/28/2013US20130317214 Method for producing maleate using wet crystal
11/28/2013US20130317213 Hepatitis C Virus Inhibitors
11/28/2013US20130317073 Methods of pest control in soybean
11/28/2013US20130317065 Indole derivative and pharmacologically acceptable salt thereof
11/28/2013US20130317057 Aldosterone synthase inhibitors
11/28/2013US20130317031 Nuclear Transport Modulators And Uses Thereof
11/28/2013US20130317028 C5aR ANTAGONISTS
11/28/2013US20130317020 Pyridyl Derivatives as CFTR Modulators
11/28/2013US20130317000 N-substituted benzamides and methods of use thereof
11/28/2013US20130316999 Substituted oxazolidinones and their use in the field of blood coagulation
11/28/2013US20130316969 Antiviral phosphonate analogs
11/28/2013US20130316904 Chiral3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole derivatives and 5,5-dimethyl-3-[(1h-pyrazol-4-ylmethyl)sulfinyl]-4,5-dihyddroisoxazole derivatives, method for the production thereof, and use of same as herbicides and plant growth regulators
11/28/2013US20130315865 Triazine compounds as pi3 kinase and mtor inhibitors
11/28/2013CA2875990A1 Heterocyclyl pyrimidine analogues as tyk2 inhibitors
11/27/2013EP2666773A1 Organic amine salts of azilsartan, preparation method and use thereof
11/27/2013EP2665726A2 Compositions and methods for cardiovascular disease
11/27/2013EP2665723A1 Process for the preparation of statins in the presence of base
11/27/2013EP2665722A1 Process for the preparation of diol sulfones
11/27/2013EP2665721A1 Methyltetrazole sulfides and sulfones
11/27/2013EP2665720A1 2-methoxy-pyridin-4-yl derivatives
11/27/2013EP2665719A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
11/27/2013EP2665713A1 1,4 oxazines as bace1 and/or bace2 inhibitors
11/27/2013EP2665711A1 Picolinamide inhibitors of kinases
11/27/2013EP2665706A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
11/27/2013EP2665704A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
11/27/2013CN103415507A 3-amino-pyridines as GPBAR1 agonists
11/27/2013CN103408540A 2-imidazole ring-substituted thiophene PLK1 (Polo-like kinase 1) inhibitors and applications thereof
11/27/2013CN103408533A Novel substituted pyridin-2-ones and pyridazin-3-ones
11/27/2013CN103408500A Preparation method for angiotensin II receptor blocker and key intermediate thereof
11/27/2013CN102659771B Lloperidone pharmaceutical co-crystal and preparation method thereof
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 647